Torben Bjerregaard Larsen

Summary

Affiliation: University of Copenhagen
Country: Denmark

Publications

  1. ncbi Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial
    Sian Robinson
    Department of Anaesthesia and Intensive Care, Odense University Hospital OUH, SDR, Odense C, Denmark
    Crit Care 14:R41. 2010
  2. ncbi The Arg506Gln mutation (FV Leiden) among a cohort of 4188 unselected Danish newborns
    T B Larsen
    Department of Clinical Biochemistry, Vejle County Central Hospital, Denmark
    Thromb Res 89:211-5. 1998
  3. ncbi Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study
    Torben Bjerregaard Larsen
    Department of Biochemistry, Pharmacology and Genetics, Odense University Hospital, Denmark
    Thromb Res 120:505-9. 2007
  4. ncbi Major genetic susceptibility for venous thromboembolism in men: a study of Danish twins
    Torben Bjerregaard Larsen
    Department of Clinical Epidemiology, Aarhus University Hospital, Aalborg, Denmark
    Epidemiology 14:328-32. 2003
  5. ncbi Platelets and anticoagulant capacity in patients with inflammatory bowel disease
    Torben Bjerregaard Larsen
    Department of Clinical Biochemistry, Section for Thrombosis and Hemostasis, Aalborg Hospital, Aalborg, Denmark
    Pathophysiol Haemost Thromb 32:92-6. 2002
  6. ncbi Validity of D-dimer tests in the diagnosis of deep vein thrombosis: a prospective comparative study of three quantitative assays
    T B Larsen
    Department of Clinical Biochemistry, Section for Thrombosis and Hemostasis, Aalborg Hospital, Aalborg, Denmark
    J Intern Med 252:36-40. 2002
  7. ncbi Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease
    Larsen T Bjerregaard
    Dept of Clinical Biochemistry, Aalborg Hospital, Denmark
    Scand J Gastroenterol 37:62-7. 2002
  8. ncbi Sudden infant death syndrome, childhood thrombosis, and presence of genetic risk factors for thrombosis
    T B Larsen
    Department of Clinical Biochemistry, Vejle County Central Hospital, Vejle, Denmark
    Thromb Res 98:233-9. 2000
  9. ncbi Effect of anticoagulant therapy on the hypercoagulable state in patients carrying the factor V Arg506Gln mutation
    T B Larsen
    Department of Clinical Biochemistry, Vejle County Central Hospital, Denmark
    Thromb Res 92:157-62. 1998
  10. ncbi ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study
    T B Larsen
    Department of Clinical Biochemistry and Genetics, Odense University Hospital, Sdr Boulevard 29, DK 5000 Odense, Denmark
    J Thromb Haemost 3:300-4. 2005

Collaborators

Detail Information

Publications22

  1. ncbi Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial
    Sian Robinson
    Department of Anaesthesia and Intensive Care, Odense University Hospital OUH, SDR, Odense C, Denmark
    Crit Care 14:R41. 2010
    ..This study aims to determine the subcutaneous (SC) dose of enoxaparin that would give the best anti-factor Xa levels in ICU patients...
  2. ncbi The Arg506Gln mutation (FV Leiden) among a cohort of 4188 unselected Danish newborns
    T B Larsen
    Department of Clinical Biochemistry, Vejle County Central Hospital, Denmark
    Thromb Res 89:211-5. 1998
    ..Equal gender distribution was found, and the Arg506Gln mutation is probably not a considerable risk factor in fetal life in the general population...
  3. ncbi Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study
    Torben Bjerregaard Larsen
    Department of Biochemistry, Pharmacology and Genetics, Odense University Hospital, Denmark
    Thromb Res 120:505-9. 2007
    ..The aim of the present study was to examine the association between smoking, obesity (BMI>30), and risk for venous thromboembolism (VTE) during pregnancy and the puerperium...
  4. ncbi Major genetic susceptibility for venous thromboembolism in men: a study of Danish twins
    Torben Bjerregaard Larsen
    Department of Clinical Epidemiology, Aarhus University Hospital, Aalborg, Denmark
    Epidemiology 14:328-32. 2003
    ..Although several genetic determinants (mutations or polymorphisms) have been associated with increased risk of venous thromboembolism, the overall influence of genetic factors on this disease is unknown...
  5. ncbi Platelets and anticoagulant capacity in patients with inflammatory bowel disease
    Torben Bjerregaard Larsen
    Department of Clinical Biochemistry, Section for Thrombosis and Hemostasis, Aalborg Hospital, Aalborg, Denmark
    Pathophysiol Haemost Thromb 32:92-6. 2002
    ....
  6. ncbi Validity of D-dimer tests in the diagnosis of deep vein thrombosis: a prospective comparative study of three quantitative assays
    T B Larsen
    Department of Clinical Biochemistry, Section for Thrombosis and Hemostasis, Aalborg Hospital, Aalborg, Denmark
    J Intern Med 252:36-40. 2002
    ..A third assay (Auto Dimer) became available during sample collection and has been included in the final assessment. The diagnostic performance of the Auto Dimer assay was evaluated on three different coagulation analysers...
  7. ncbi Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease
    Larsen T Bjerregaard
    Dept of Clinical Biochemistry, Aalborg Hospital, Denmark
    Scand J Gastroenterol 37:62-7. 2002
    ....
  8. ncbi Sudden infant death syndrome, childhood thrombosis, and presence of genetic risk factors for thrombosis
    T B Larsen
    Department of Clinical Biochemistry, Vejle County Central Hospital, Vejle, Denmark
    Thromb Res 98:233-9. 2000
    ....
  9. ncbi Effect of anticoagulant therapy on the hypercoagulable state in patients carrying the factor V Arg506Gln mutation
    T B Larsen
    Department of Clinical Biochemistry, Vejle County Central Hospital, Denmark
    Thromb Res 92:157-62. 1998
    ..Thus, it seems that OAT with standard treatment doses is just as effective in patients with the Arg506Gln mutation as in comparable controls without the mutation...
  10. ncbi ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study
    T B Larsen
    Department of Clinical Biochemistry and Genetics, Odense University Hospital, Sdr Boulevard 29, DK 5000 Odense, Denmark
    J Thromb Haemost 3:300-4. 2005
    ..To examine possible associations of ABO blood types with the risk of venous thromboembolism (VTE) in pregnancy and the puerperium...
  11. ncbi Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis
    Lars Hvilsted Rasmussen
    Thrombosis Research Unit, Aalborg University, Aalborg, Denmark
    BMJ 345:e7097. 2012
    ..A secondary objective was to do the same analysis in the primary prevention cohort...
  12. ncbi Added predictive ability of the CHA2DS2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish Diet, Cancer, and Health cohort study
    Torben Bjerregaard Larsen
    Department of Cardiology, Aalborg AF Study Group, Cardiovascular Research Centre, Aarhus University Hospital, Aalborg, Denmark
    Circ Cardiovasc Qual Outcomes 5:335-42. 2012
    ..The objective of this study was to evaluate the added predictive ability of the CHA(2)DS(2)VASc prediction rule for stroke and death in a nonanticoagulated population of patients with atrial fibrillation...
  13. ncbi A review of medical records and discharge summary data found moderate to high predictive values of discharge diagnoses of venous thromboembolism during pregnancy and postpartum
    Torben Bjerregaard Larsen
    Department of Clinical Biochemistry and Genetics, Section for Thrombosis and Haemostasis, Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense, Denmark; Department of Clinical Epidemiology, Aarhus University Hospitals, DK-8000, Aarhus C, Denmark
    J Clin Epidemiol 58:316-9. 2005
    ..Thus, use of unvalidated registry-based pregnancy-related VTE diagnoses for epidemiological research may lead to biased results...
  14. ncbi Combined use of clinical pre-test probability and D-dimer test in the diagnosis of preoperative deep venous thrombosis in colorectal cancer patients
    Mogens Tornby Stender
    Department of Surgical Gastroenterology A, Aalborg Hospital, Aarhus University Hospital, Hobrovej 18 22, Aalborg, Denmark
    Thromb Haemost 99:396-400. 2008
    ..In conclusion, the combined use of pre-test probability and D-dimer test may be useful in ruling out preoperative DVT in colorectal cancer patients admitted for surgery...
  15. ncbi [Diagnostics: new methodological initiatives]
    Erik Magid
    Amager Hospital, Klinisk Biokemisk Afdeling
    Ugeskr Laeger 166:1664-6. 2004
  16. ncbi Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation
    Gregory Y H Lip
    University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK
    J Am Coll Cardiol 60:738-46. 2012
    ..This study sought to perform an indirect comparison analysis of dabigatran etexilate (2 doses), rivaroxaban, and apixaban for their relative efficacy and safety against each other...
  17. ncbi Self-testing and self-management of oral anticoagulation therapy in children
    Thomas Decker Christensen
    Thomas Decker Christensen, Department of Cardiothoracic and Vascular Surgery and Institute of Clinical Medicine, Aarhus University Hospital, Skejby, DK 8200 Aarhus N, Denmark
    Thromb Haemost 106:391-7. 2011
    ....
  18. ncbi High preoperative prevalence of deep venous thrombosis in patients with colorectal cancer
    M T Stender
    Department of Surgical Gastroenterology, Aalborg Hospital, Aarhus University Hospital, Hobrovej 18 22, DK 9100 Aalborg, Denmark
    Br J Surg 94:1100-3. 2007
    ..The aim of this observational study was to estimate the preoperative prevalence of DVT in patients with colorectal cancer...
  19. ncbi Evaluation of a simple dosage scheme for transition from phenprocoumon to warfarin in oral anticoagulation
    C Kristiansen
    Department of Clinical Biochemistry, Vejle County Central Hospital, DK 7100, Vejle, Denmark
    Thromb Res 98:157-63. 2000
    ..No patients experienced haemorrhages or thromboembolic complications during the period of changeover. In conclusion, the proposed scheme for changing medication from phenprocoumon to warfarin is safe and convenient...
  20. ncbi Denaturing high-performance liquid chromatography mutation analysis in patients with reduced Protein S levels
    Lise Bathum
    Department of Biochemistry, Pharmacology and Genetics, Odense University Hospital, Denmark
    Clin Chim Acta 390:76-81. 2008
    ..The aim was to design a high-throughput genetic analysis based on denaturing high-performance liquid chromatography to identify sequence variations in the gene coding for Protein S...
  21. ncbi [The Danish clinical guidelines (Klaringsrapporter, 1996-2001: Insufficient evidence presented for the diagnostic accuracy of recommended clinical-biochemical tests]
    Per E Jørgensen
    Odense Universitetshospital, Afdeling KKA
    Ugeskr Laeger 166:1667-70. 2004
  22. ncbi More studies on outcomes using biochemical diagnostic tests are needed: findings from the Danish Society of Clinical Biochemistry
    Jonna Skov Madsen
    Clin Chem 54:1254-6. 2008